chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 74.0
Sex: F
Vaccine: PPV
Symptoms: Mass, Motor dysfunction, Pain
Clinical narrative: Total loss of motor control in that arm for 2 days, slowly regained to normal in 6 weeks. Still experiencing occasional pain after 3 months. Can feel lump in arm.  If that can happen to an adult, what would it do to a child? Contribute to autism? Also extreme agony the first few days.
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Asthenia, Chills, Dizziness, Dyspnoea, Encephalopathy
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Fatigue, Feeling abnormal, Flushing, Headache, Hypoaesthesia
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Hypotension, Influenza like illness, Lymphadenopathy, Malaise, Muscular weakness
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Myalgia, Neuropathy peripheral, Pain, Paraesthesia, Petechiae
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Photophobia, Visual impairment
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Altered state of consciousness, Amnesia, Cognitive disorder, Disorientation, Encephalopathy
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Feeling abnormal, Hypoaesthesia, Incorrect dose administered, Paraesthesia, Visual impairment
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Asthenia, Blood test normal, Cognitive disorder, Fatigue, Feeling abnormal
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 18.0
Sex: M
Vaccine: HEP, HEP, HEPA, HEP, HEPA
Symptoms: Laboratory test normal, Memory impairment
Clinical narrative: Encephalopathy (brain fog)  fatigue  dizziness  headache  lymphadenopathy  tingling  flushing hypotention petechiae myalgia pain chills influenza-like symptoms malaise weakness neuropathy including hypoesthesia (numbness, tingling)  paresthesia visual disturbances (light sensitivity)  muscular weakness shortness of breath
Age: 46.0
Sex: F
Vaccine: DPP
Symptoms: Injection site swelling
Clinical narrative: Swollen injection site in left upper tricep area which expanded over time to encompass the whole bicep and tricep.  Could not be covered by clothing.  This lasted more than 10 days.
Age: 1.19
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Convulsion
Clinical narrative: AFTER 15 MINUTES OF VACCINE ADMINISTRATION THE PATIENT BEGAN CONVULSING.
Sex: U
Vaccine: TDAP
Symptoms: Anaphylactic reaction
Clinical narrative: Initial report was received 02 May 2011 from the above referenced scientific literature report which described ongoing research involving eight milk allergic children who received either Tdap or DTaP vaccinations and within one hour after vaccination, experienced anaphylactic reactions. These events occurred between September 2007 and March 2010 (captured in case number 2011-01614). According to the literature report, during that same period, the national Vaccine Adverse Event Reporting System (VAERS) listed only 42 anaphylactic reactions for patients under 17 years old to the Tdap and DTaP vaccines (manufacturers unknown, lot numbers not reported). This information was noted in the literature report as being obtained from a poster which had been presented by a physician at the Academy of Allergy, Asthma and Immunology. Outcomes were not reported. No additional information was provided at the time of the report. The reporter for this case is the same as for case numbers 2011-01614 and 2011-01616. Documents held by sender: none.
Age: 22.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Abdominal pain, Chills, Feeling cold, Muscle spasms, Nausea
Clinical narrative: Started feeling achy and feeling extremely cold, shaking like chills. Some nausea and abdominal pain (crampy type pain). She did not take her temperature. Had problems most of the night, but felt fine the next AM.
Age: 22.0
Sex: F
Vaccine: HPV4, TDAP
Symptoms: Pain, Tremor
Clinical narrative: Started feeling achy and feeling extremely cold, shaking like chills. Some nausea and abdominal pain (crampy type pain). She did not take her temperature. Had problems most of the night, but felt fine the next AM.
Age: 82.0
Sex: F
Vaccine: TD
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling & erythema at injection site.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Diarrhoea, Rotavirus test positive, Vomiting
Clinical narrative: 2 mo old (ex 29 wk) received ROTATEQ vaccine on 5/6/11, presented to PMD on 5/9/11 with complains of watery stools for 2 days, next day developed vomiting.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Excoriation, Papule, Skin lesion
Clinical narrative: Scattered areas of papular lesions w/ superficial sl excoriations - posterior LUE, (R) flank, periumbilical and suprapubic - was noticed 3 days after vaccine.
Age: 0.16
Sex: M
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Crying, Diet refusal, Injection site swelling
Clinical narrative: Patient had inconsolable crying, would not eat, upon examination, right thigh swollen - no increased redness. Left thigh ok. Temp WNL 97 degrees tympanic. Re exam done at 1730 - TMS clear, pink good cap refill. Pt calm in mom's arms, resting quietly with eyes close. Nursing successful.
Age: 56.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Headache
Clinical narrative: Patient received vaccination for Hep B about 12pm in office. Around 2pm that same day she began to experience extreme dizziness followed by a h/a. Symptom relieved by going to bed. Symptoms resolved the next morning.
Age: 1.01
Sex: M
Vaccine: DTAP, DTP, MEA
Symptoms: Asterixis, Eye movement disorder, Head circumference abnormal, Social avoidant behaviour
Clinical narrative: noticed he became withdrawn acting as if he couldn't hear developed rapid eye movement hand flapping type movement by his 2 year birthday his head was irregular with a protruding forehead
Age: 10.0
Sex: M
Vaccine: VARCEL
Symptoms: Unevaluable event
Clinical narrative: None stated.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: C-reactive protein normal, Full blood count normal, Injection site pain, Nasal congestion, Pain
Clinical narrative: Rcvd flu vaccine 10/29/10. States within 6 days, had (+) body aches, nasal congestion, occ. fever. Soreness at injection site. States 3rd year this has happened. VAERS report filed 10/7/08. No reports of any problem with 2009 flu shot. Had ov 12/20/10 for above sx. CBC-NL, CRP-NL, RF 22(H), ESR-NL. Doxycycline 100mg bid x 7 days. 1/3/11 c/o "flu-like" sx. nasal cong, sinus pressure, nausea. Only took Doxycycline x 3d. 5/6/11 - Spoke with pt. - feels well.
Age: 71.0
Sex: M
Vaccine: FLU3
Symptoms: Pyrexia, Red blood cell sedimentation rate normal, Rheumatoid factor negative
Clinical narrative: Rcvd flu vaccine 10/29/10. States within 6 days, had (+) body aches, nasal congestion, occ. fever. Soreness at injection site. States 3rd year this has happened. VAERS report filed 10/7/08. No reports of any problem with 2009 flu shot. Had ov 12/20/10 for above sx. CBC-NL, CRP-NL, RF 22(H), ESR-NL. Doxycycline 100mg bid x 7 days. 1/3/11 c/o "flu-like" sx. nasal cong, sinus pressure, nausea. Only took Doxycycline x 3d. 5/6/11 - Spoke with pt. - feels well.
Age: 20.0
Sex: F
Vaccine: MNQ
Symptoms: Asthenia, Dizziness, Headache, Pain in extremity
Clinical narrative: See attached progress note. 1pm on 5-5-11 dizzy, weak progressed throughout afternoon to foot & leg pain. She also developed a headache & arm pain.
Age: 1.3
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Irritability, Rash
Clinical narrative: Fussiness and rash without fever started 5/10/11.
Age: 37.0
Sex: F
Vaccine: TDAP
Symptoms: Chest discomfort, Dyspnoea, Injection site erythema, Pruritus, Rash
Clinical narrative: After 7 hrs of post Tdap injection, notice itchiness of chin and neck. The next morning woke up with rashes of Rt side face, eye, neck and chest and gen. rashes to back and abdomen. Redness to injection site with chest tightness and short of breath. Went to Emerg. Dept, prescribed with SOLUMEDROL IV, PEPCID, BENADRYL and IV hydration.
Age: 5.0
Sex: M
Vaccine: FLUX
Symptoms: Abnormal behaviour, Adverse drug reaction, Blood culture negative, Brain scan normal, Computerised tomogram head
Clinical narrative: Case number PHHY2011AR38458, is a spontaneous report from a physician received on 05 May 2011: This report refers to a 5-year-old male patient. He was vaccinated with AGRIPPAL S1 (batch number unknown) on 28 Apr 2011. The patient was healthy before vaccination. On 29 Apr 2011, 24 hours after vaccination, the patient started with behavioral disorders and experienced afebrile tonic-clonic seizure on the right side of her body, and then it was generalized with vomiting and ocular retroversion. The patient arrived to the emergency room of the clinic on post-ictal state where anticonvulsants were administered. Due to respiratory depression caused by drugs (unspecified), the patient was intubated. Then, the patient was transferred to other clinic. Different investigational studies were performed. Computed brain scan, electroencephalogram (EEG), cephalo-rachidian-liquid (CRL) puncture were normal and blood cultures were negative. Polymerase chain reaction (PCR) for Epstein-Barr virus (EMB), cytomegalovirus (CMV) and enteroviruses were negative. Neurological examination was normal. The patient was treated with ceftriaxone, acyclovir and anticonvulsants. At the time of this report, the child was completely recovered.
Age: 5.0
Sex: M
Vaccine: FLUX
Symptoms: Cytomegalovirus test negative, Electroencephalogram normal, Endotracheal intubation, Enterovirus test negative, Epstein-Barr virus test negative
Clinical narrative: Case number PHHY2011AR38458, is a spontaneous report from a physician received on 05 May 2011: This report refers to a 5-year-old male patient. He was vaccinated with AGRIPPAL S1 (batch number unknown) on 28 Apr 2011. The patient was healthy before vaccination. On 29 Apr 2011, 24 hours after vaccination, the patient started with behavioral disorders and experienced afebrile tonic-clonic seizure on the right side of her body, and then it was generalized with vomiting and ocular retroversion. The patient arrived to the emergency room of the clinic on post-ictal state where anticonvulsants were administered. Due to respiratory depression caused by drugs (unspecified), the patient was intubated. Then, the patient was transferred to other clinic. Different investigational studies were performed. Computed brain scan, electroencephalogram (EEG), cephalo-rachidian-liquid (CRL) puncture were normal and blood cultures were negative. Polymerase chain reaction (PCR) for Epstein-Barr virus (EMB), cytomegalovirus (CMV) and enteroviruses were negative. Neurological examination was normal. The patient was treated with ceftriaxone, acyclovir and anticonvulsants. At the time of this report, the child was completely recovered.
Age: 5.0
Sex: M
Vaccine: FLUX
Symptoms: Gaze palsy, Grand mal convulsion, Lumbar puncture normal, Neurological examination normal, Polymerase chain reaction
Clinical narrative: Case number PHHY2011AR38458, is a spontaneous report from a physician received on 05 May 2011: This report refers to a 5-year-old male patient. He was vaccinated with AGRIPPAL S1 (batch number unknown) on 28 Apr 2011. The patient was healthy before vaccination. On 29 Apr 2011, 24 hours after vaccination, the patient started with behavioral disorders and experienced afebrile tonic-clonic seizure on the right side of her body, and then it was generalized with vomiting and ocular retroversion. The patient arrived to the emergency room of the clinic on post-ictal state where anticonvulsants were administered. Due to respiratory depression caused by drugs (unspecified), the patient was intubated. Then, the patient was transferred to other clinic. Different investigational studies were performed. Computed brain scan, electroencephalogram (EEG), cephalo-rachidian-liquid (CRL) puncture were normal and blood cultures were negative. Polymerase chain reaction (PCR) for Epstein-Barr virus (EMB), cytomegalovirus (CMV) and enteroviruses were negative. Neurological examination was normal. The patient was treated with ceftriaxone, acyclovir and anticonvulsants. At the time of this report, the child was completely recovered.
Age: 5.0
Sex: M
Vaccine: FLUX
Symptoms: Postictal state, Respiratory depression, Vomiting
Clinical narrative: Case number PHHY2011AR38458, is a spontaneous report from a physician received on 05 May 2011: This report refers to a 5-year-old male patient. He was vaccinated with AGRIPPAL S1 (batch number unknown) on 28 Apr 2011. The patient was healthy before vaccination. On 29 Apr 2011, 24 hours after vaccination, the patient started with behavioral disorders and experienced afebrile tonic-clonic seizure on the right side of her body, and then it was generalized with vomiting and ocular retroversion. The patient arrived to the emergency room of the clinic on post-ictal state where anticonvulsants were administered. Due to respiratory depression caused by drugs (unspecified), the patient was intubated. Then, the patient was transferred to other clinic. Different investigational studies were performed. Computed brain scan, electroencephalogram (EEG), cephalo-rachidian-liquid (CRL) puncture were normal and blood cultures were negative. Polymerase chain reaction (PCR) for Epstein-Barr virus (EMB), cytomegalovirus (CMV) and enteroviruses were negative. Neurological examination was normal. The patient was treated with ceftriaxone, acyclovir and anticonvulsants. At the time of this report, the child was completely recovered.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Oedema
Clinical narrative: red and edematous area approximately 2 inches in diameter
Age: 69.0
Sex: M
Vaccine: FLUX
Symptoms: Autopsy, Balance disorder, Blood pressure decreased, Botulism, CSF glucose increased
Clinical narrative: Case number PHHO2011US07292, is an initial report received on 26 Apr 2011, from a clinical study. This 70-year-old male subject was enrolled in a study. The subject's medical history included hyperlipidemia and cancer of left breast. Concomitant medications included Simvastatin. The subject received the study vaccine on 03 Sep 2010 at 13:15. On 18 Apr 2011, the subject was taken to the hospital for evaluation of dizziness and headaches. The same day, the subject experienced botulism and quadriparesis. The subject was unsteady on their feet and was weak in the upper extremities. The subject experienced progressive weakness and quadriplegia. The subject was seen by a neurosurgeon and neurologist. The subject underwent an MRI scan which showed spinal stenosis and multiple levels of degenerative disk with diffuse bulging and osteophyte formation. The investigator stated that per the neurosurgeon, did not cause the quadriparesis. An MRI scan of the brain revealed moderate microvascular disease. A CT scan of the head showed no evidence of acute cranial or intracranial abnormality. The subject was treated with Aspirin and DECADRON and some improvement in status was noted. The subject was placed on 'JV' for atypical presentation of Guillain-Barre syndrome. The subject was started on Doxycycline. The subject had a CT myelogram, a lumbar puncture and their antibody cultures were collected. The patient's protein was normal. In the subject's CSF fluid it was noted that their glucose level was increased (assessed as not clinically significant by the investigator). On 21 Apr 2011, the subject was transferred to ICU and signed a DNR (do not resuscitate). The subject refused to be intubated and refused a N16 and foley catheter placement. The subject's condition deteriorated with desaturation 100% and blood pressure dropped. The subject was started on a dopamine drip, maximum dose. The subject experienced respiratory muscle paralysis. On 21 Apr 2011, at 03:38am, the subject died. An autopsy was performed, and results are pending. The seriousness for botulism as life threatening and fatal, quadriparesis was disability and respiratory muscle paralysis was fatal. The outcome of the quadriparesis was condition deteriorating. The investigator suspected a relationship between the botulism, quadriparesis and respiratory muscle paralysis and the study vaccine. Follow up received on 04 May 2011: Patient's sex corrected, lab tests updated, events updated, death details updated, treatments provided, causalities updated.
Age: 69.0
Sex: M
Vaccine: FLUX
Symptoms: Computerised tomogram head, Computerised tomogram normal, Death, Dizziness, Headache
Clinical narrative: Case number PHHO2011US07292, is an initial report received on 26 Apr 2011, from a clinical study. This 70-year-old male subject was enrolled in a study. The subject's medical history included hyperlipidemia and cancer of left breast. Concomitant medications included Simvastatin. The subject received the study vaccine on 03 Sep 2010 at 13:15. On 18 Apr 2011, the subject was taken to the hospital for evaluation of dizziness and headaches. The same day, the subject experienced botulism and quadriparesis. The subject was unsteady on their feet and was weak in the upper extremities. The subject experienced progressive weakness and quadriplegia. The subject was seen by a neurosurgeon and neurologist. The subject underwent an MRI scan which showed spinal stenosis and multiple levels of degenerative disk with diffuse bulging and osteophyte formation. The investigator stated that per the neurosurgeon, did not cause the quadriparesis. An MRI scan of the brain revealed moderate microvascular disease. A CT scan of the head showed no evidence of acute cranial or intracranial abnormality. The subject was treated with Aspirin and DECADRON and some improvement in status was noted. The subject was placed on 'JV' for atypical presentation of Guillain-Barre syndrome. The subject was started on Doxycycline. The subject had a CT myelogram, a lumbar puncture and their antibody cultures were collected. The patient's protein was normal. In the subject's CSF fluid it was noted that their glucose level was increased (assessed as not clinically significant by the investigator). On 21 Apr 2011, the subject was transferred to ICU and signed a DNR (do not resuscitate). The subject refused to be intubated and refused a N16 and foley catheter placement. The subject's condition deteriorated with desaturation 100% and blood pressure dropped. The subject was started on a dopamine drip, maximum dose. The subject experienced respiratory muscle paralysis. On 21 Apr 2011, at 03:38am, the subject died. An autopsy was performed, and results are pending. The seriousness for botulism as life threatening and fatal, quadriparesis was disability and respiratory muscle paralysis was fatal. The outcome of the quadriparesis was condition deteriorating. The investigator suspected a relationship between the botulism, quadriparesis and respiratory muscle paralysis and the study vaccine. Follow up received on 04 May 2011: Patient's sex corrected, lab tests updated, events updated, death details updated, treatments provided, causalities updated.
Age: 69.0
Sex: M
Vaccine: FLUX
Symptoms: Intensive care, Lumbar puncture, Muscular weakness, Nuclear magnetic resonance imaging abnormal, Nuclear magnetic resonance imaging spinal cord abnormal
Clinical narrative: Case number PHHO2011US07292, is an initial report received on 26 Apr 2011, from a clinical study. This 70-year-old male subject was enrolled in a study. The subject's medical history included hyperlipidemia and cancer of left breast. Concomitant medications included Simvastatin. The subject received the study vaccine on 03 Sep 2010 at 13:15. On 18 Apr 2011, the subject was taken to the hospital for evaluation of dizziness and headaches. The same day, the subject experienced botulism and quadriparesis. The subject was unsteady on their feet and was weak in the upper extremities. The subject experienced progressive weakness and quadriplegia. The subject was seen by a neurosurgeon and neurologist. The subject underwent an MRI scan which showed spinal stenosis and multiple levels of degenerative disk with diffuse bulging and osteophyte formation. The investigator stated that per the neurosurgeon, did not cause the quadriparesis. An MRI scan of the brain revealed moderate microvascular disease. A CT scan of the head showed no evidence of acute cranial or intracranial abnormality. The subject was treated with Aspirin and DECADRON and some improvement in status was noted. The subject was placed on 'JV' for atypical presentation of Guillain-Barre syndrome. The subject was started on Doxycycline. The subject had a CT myelogram, a lumbar puncture and their antibody cultures were collected. The patient's protein was normal. In the subject's CSF fluid it was noted that their glucose level was increased (assessed as not clinically significant by the investigator). On 21 Apr 2011, the subject was transferred to ICU and signed a DNR (do not resuscitate). The subject refused to be intubated and refused a N16 and foley catheter placement. The subject's condition deteriorated with desaturation 100% and blood pressure dropped. The subject was started on a dopamine drip, maximum dose. The subject experienced respiratory muscle paralysis. On 21 Apr 2011, at 03:38am, the subject died. An autopsy was performed, and results are pending. The seriousness for botulism as life threatening and fatal, quadriparesis was disability and respiratory muscle paralysis was fatal. The outcome of the quadriparesis was condition deteriorating. The investigator suspected a relationship between the botulism, quadriparesis and respiratory muscle paralysis and the study vaccine. Follow up received on 04 May 2011: Patient's sex corrected, lab tests updated, events updated, death details updated, treatments provided, causalities updated.
Age: 69.0
Sex: M
Vaccine: FLUX
Symptoms: Protein total normal, Quadriparesis, Quadriplegia, Respiratory paralysis, Spinal myelogram
Clinical narrative: Case number PHHO2011US07292, is an initial report received on 26 Apr 2011, from a clinical study. This 70-year-old male subject was enrolled in a study. The subject's medical history included hyperlipidemia and cancer of left breast. Concomitant medications included Simvastatin. The subject received the study vaccine on 03 Sep 2010 at 13:15. On 18 Apr 2011, the subject was taken to the hospital for evaluation of dizziness and headaches. The same day, the subject experienced botulism and quadriparesis. The subject was unsteady on their feet and was weak in the upper extremities. The subject experienced progressive weakness and quadriplegia. The subject was seen by a neurosurgeon and neurologist. The subject underwent an MRI scan which showed spinal stenosis and multiple levels of degenerative disk with diffuse bulging and osteophyte formation. The investigator stated that per the neurosurgeon, did not cause the quadriparesis. An MRI scan of the brain revealed moderate microvascular disease. A CT scan of the head showed no evidence of acute cranial or intracranial abnormality. The subject was treated with Aspirin and DECADRON and some improvement in status was noted. The subject was placed on 'JV' for atypical presentation of Guillain-Barre syndrome. The subject was started on Doxycycline. The subject had a CT myelogram, a lumbar puncture and their antibody cultures were collected. The patient's protein was normal. In the subject's CSF fluid it was noted that their glucose level was increased (assessed as not clinically significant by the investigator). On 21 Apr 2011, the subject was transferred to ICU and signed a DNR (do not resuscitate). The subject refused to be intubated and refused a N16 and foley catheter placement. The subject's condition deteriorated with desaturation 100% and blood pressure dropped. The subject was started on a dopamine drip, maximum dose. The subject experienced respiratory muscle paralysis. On 21 Apr 2011, at 03:38am, the subject died. An autopsy was performed, and results are pending. The seriousness for botulism as life threatening and fatal, quadriparesis was disability and respiratory muscle paralysis was fatal. The outcome of the quadriparesis was condition deteriorating. The investigator suspected a relationship between the botulism, quadriparesis and respiratory muscle paralysis and the study vaccine. Follow up received on 04 May 2011: Patient's sex corrected, lab tests updated, events updated, death details updated, treatments provided, causalities updated.
Age: 23.0
Sex: F
Vaccine: TDAP
Symptoms: Dyspnoea, Malaise, Nausea, Painful respiration, Pyrexia
Clinical narrative: Nausea, vomiting, fever, malaise, Shortness of breath with pain on inspiration.
Age: 23.0
Sex: F
Vaccine: TDAP
Symptoms: Vomiting
Clinical narrative: Nausea, vomiting, fever, malaise, Shortness of breath with pain on inspiration.
Age: 1.26
Sex: M
Vaccine: HEP
Symptoms: Pyrexia, Rash, Vomiting
Clinical narrative: pt had fever for 4-5 days of 102.6 rash for 2-3 days and vomited
Age: 71.0
Sex: F
Vaccine: PPV
Symptoms: Administration site pain, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: pain, redness, warmth, and swelling of upper right arm at deltoid area where pneumonia vaccine had been administered the day before
Age: 48.0
Sex: M
Vaccine: TDAP
Symptoms: Chills, Headache, Nausea, Pain, Pyrexia
Clinical narrative: Developed nausea about 6 hrs after receiving Tdap vaccine which lasted for 2 hrs then developed chills for 2 hours then for the next 15 hours he had a mild fever, headache & body aches.
Age: 11.0
Sex: F
Vaccine: MNQ, VARCEL
Symptoms: Allergy to vaccine, Erythema, Pain, Swelling
Clinical narrative: Pt came back because allergic reaction to MCV 4, side was red & swollen, pt didn't have no temp. Pt told to apply ice to area & take Ibuprofen or TYLENOL for pain.
Age: 0.35
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Blood test, Clostridium test, Culture stool, Haematochezia, Mucous stools
Clinical narrative: Mucousy bloody stools starting 7 days after vaccines.
Age: 55.0
Sex: M
Vaccine: HEPAB
Symptoms: Blood glucose increased, Diabetes mellitus inadequate control
Clinical narrative: This case was reported by the sister of a consumer and described the occurrence of uncontrolled blood glucose level in a 55-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included diabetes mellitus and hepatitis C. Previous vaccination included 1st dose TWINRIX (GlaxoSmithKline) given on an unspecified date. Concurrent medications included Glipizide. On an unspecified date the subject received 2nd dose of TWINRIX (unknown). At an unspecified time after vaccination with TWINRIX, the subject experienced uncontrolled blood glucose level. Glucose levels of 240 were unusual for the subject and not being controlled by his oral medication glipizide. This case was assessed as medically serious by GSK. At the time of reporting the event was unresolved.
Age: 56.0
Sex: M
Vaccine: VARZOS
Symptoms: Migraine
Clinical narrative: Severe migraine started 2 hours after vaccination (7 pm) and stopped 48 hours later.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Child received vaccines in our office 5/9/11 - 5/10/11 in PM - mother noted (L) upper anterior-lateral arm - red, swollen, painful. Mom called office/call service - told to give MOTRIN.
Age: 60.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Body temperature increased, Cough, Headache, Injected limb mobility decreased, Injection site erythema
Clinical narrative: In morning: temp - 101.3, injection site pain, redness, swelling, extreme pain at site. By evening: temp 103, general achiness, headache, dry cough. 05/06/2011 at 3:00 AM: Temp 105, severe headache, productive cough. Symptoms continued for 4 days. Residual local reaction at injection site continues with severe pain, swelling, redness, warmth causing limited range of motion left arm.
Age: 60.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site pain, Injection site swelling, Injection site warmth, Local reaction, Pain
Clinical narrative: In morning: temp - 101.3, injection site pain, redness, swelling, extreme pain at site. By evening: temp 103, general achiness, headache, dry cough. 05/06/2011 at 3:00 AM: Temp 105, severe headache, productive cough. Symptoms continued for 4 days. Residual local reaction at injection site continues with severe pain, swelling, redness, warmth causing limited range of motion left arm.
Age: 60.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Productive cough
Clinical narrative: In morning: temp - 101.3, injection site pain, redness, swelling, extreme pain at site. By evening: temp 103, general achiness, headache, dry cough. 05/06/2011 at 3:00 AM: Temp 105, severe headache, productive cough. Symptoms continued for 4 days. Residual local reaction at injection site continues with severe pain, swelling, redness, warmth causing limited range of motion left arm.
Age: 12.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Rash
Clinical narrative: Rash to face
Age: 12.0
Sex: M
Vaccine: HPV4, HPV4
Symptoms: Rash, Rash pruritic
Clinical narrative: Rash to face
Age: 4.0
Sex: F
Vaccine: FLUN3
Symptoms: Swelling face, VIIth nerve paralysis
Clinical narrative: Paralysis and drooping of left side of face, puffy left cheek.  Dx - Bell's Palsy.
Age: 40.0
Sex: F
Vaccine: MMR
Symptoms: Arthralgia, Joint swelling, Laboratory test
Clinical narrative: Pt. reported joint pain in knees started on 5/3/11. She saw MD on 5/10/11 when lab work was done. The joint pain and swelling continued and spread to other joints this started on 5/5/11 and is on-going. Pt reported some improvement on 5/10/11.
Age: 18.0
Sex: M
Vaccine: FLU3, IPV, TD
Symptoms: Dyspnoea, Fatigue, Guillain-Barre syndrome, Headache, Infectious mononucleosis
Clinical narrative: A hx of GBS post vaccinations in 2007. Per medical records review the SM was vaccinated with Influenza, IPV, MCV4 and TD on 20 Apr 2007. On 25 Apr he received Hep-A #1 and on 19 May 07 he was evaluated for an URI. on 20 Jun 07, 8 wks post vaccination he was evaluated for viral syndrome with sensory changes to his fingers. Symptoms worsened and he was diagnosed with Bell's palsy on 23 Jun 07 and was hospitalized with GBS-Miller Fisher Variant on 25 Jun 07. He received his influenza vaccine in Nov 07 and Hep-A #2 on Dec 07 with no recurrence of symptoms. On 11 Mar 08 he received AVA #1, SPV, and typhoid. On 13 Mar he was evaluated for a 2 wk hx of flu like sx, and was diagnosed as having pharyngitis. On 07 Apr 08 he was due to receive AVA #2 (reports that AVA #2 was admin), he presented to immunizations but required a walk in visit for evaluation for headache for 2 days and facial tingling. Neuro was consulted and noted that sx likely related to recent AVA, which could unmask previous damage caused by GBS. Per T-con he was reported as doing well on 10 Apr 08, and on 14 Apr he denied any new numbness/tingling, no worsening of previous sx but did report generalized fatigue. On 15 Apr 08 he reported sx have resolved but is now having trouble breathing and SOB with activity. Sx were assessed as not being consistent with GBS and labs were ordered. On 17 Apr pt was told that he had mono with a pos heterophile Ab; his sx included fatigue, sore throat and malaise. Since Apr 08, he has not received any additional vaccinations, was deployed, and has had no recurrent symptoms.
Age: 18.0
Sex: M
Vaccine: FLU3, IPV, TD
Symptoms: Influenza like illness, Laboratory test, Malaise, Miller Fisher syndrome, Mononucleosis heterophile test positive
Clinical narrative: A hx of GBS post vaccinations in 2007. Per medical records review the SM was vaccinated with Influenza, IPV, MCV4 and TD on 20 Apr 2007. On 25 Apr he received Hep-A #1 and on 19 May 07 he was evaluated for an URI. on 20 Jun 07, 8 wks post vaccination he was evaluated for viral syndrome with sensory changes to his fingers. Symptoms worsened and he was diagnosed with Bell's palsy on 23 Jun 07 and was hospitalized with GBS-Miller Fisher Variant on 25 Jun 07. He received his influenza vaccine in Nov 07 and Hep-A #2 on Dec 07 with no recurrence of symptoms. On 11 Mar 08 he received AVA #1, SPV, and typhoid. On 13 Mar he was evaluated for a 2 wk hx of flu like sx, and was diagnosed as having pharyngitis. On 07 Apr 08 he was due to receive AVA #2 (reports that AVA #2 was admin), he presented to immunizations but required a walk in visit for evaluation for headache for 2 days and facial tingling. Neuro was consulted and noted that sx likely related to recent AVA, which could unmask previous damage caused by GBS. Per T-con he was reported as doing well on 10 Apr 08, and on 14 Apr he denied any new numbness/tingling, no worsening of previous sx but did report generalized fatigue. On 15 Apr 08 he reported sx have resolved but is now having trouble breathing and SOB with activity. Sx were assessed as not being consistent with GBS and labs were ordered. On 17 Apr pt was told that he had mono with a pos heterophile Ab; his sx included fatigue, sore throat and malaise. Since Apr 08, he has not received any additional vaccinations, was deployed, and has had no recurrent symptoms.
Age: 18.0
Sex: M
Vaccine: FLU3, IPV, TD
Symptoms: Oropharyngeal pain, Paraesthesia, Pharyngitis, Sensory disturbance, Upper respiratory tract infection
Clinical narrative: A hx of GBS post vaccinations in 2007. Per medical records review the SM was vaccinated with Influenza, IPV, MCV4 and TD on 20 Apr 2007. On 25 Apr he received Hep-A #1 and on 19 May 07 he was evaluated for an URI. on 20 Jun 07, 8 wks post vaccination he was evaluated for viral syndrome with sensory changes to his fingers. Symptoms worsened and he was diagnosed with Bell's palsy on 23 Jun 07 and was hospitalized with GBS-Miller Fisher Variant on 25 Jun 07. He received his influenza vaccine in Nov 07 and Hep-A #2 on Dec 07 with no recurrence of symptoms. On 11 Mar 08 he received AVA #1, SPV, and typhoid. On 13 Mar he was evaluated for a 2 wk hx of flu like sx, and was diagnosed as having pharyngitis. On 07 Apr 08 he was due to receive AVA #2 (reports that AVA #2 was admin), he presented to immunizations but required a walk in visit for evaluation for headache for 2 days and facial tingling. Neuro was consulted and noted that sx likely related to recent AVA, which could unmask previous damage caused by GBS. Per T-con he was reported as doing well on 10 Apr 08, and on 14 Apr he denied any new numbness/tingling, no worsening of previous sx but did report generalized fatigue. On 15 Apr 08 he reported sx have resolved but is now having trouble breathing and SOB with activity. Sx were assessed as not being consistent with GBS and labs were ordered. On 17 Apr pt was told that he had mono with a pos heterophile Ab; his sx included fatigue, sore throat and malaise. Since Apr 08, he has not received any additional vaccinations, was deployed, and has had no recurrent symptoms.
Age: 18.0
Sex: M
Vaccine: FLU3, IPV, TD
Symptoms: VIIth nerve paralysis, Viral infection
Clinical narrative: A hx of GBS post vaccinations in 2007. Per medical records review the SM was vaccinated with Influenza, IPV, MCV4 and TD on 20 Apr 2007. On 25 Apr he received Hep-A #1 and on 19 May 07 he was evaluated for an URI. on 20 Jun 07, 8 wks post vaccination he was evaluated for viral syndrome with sensory changes to his fingers. Symptoms worsened and he was diagnosed with Bell's palsy on 23 Jun 07 and was hospitalized with GBS-Miller Fisher Variant on 25 Jun 07. He received his influenza vaccine in Nov 07 and Hep-A #2 on Dec 07 with no recurrence of symptoms. On 11 Mar 08 he received AVA #1, SPV, and typhoid. On 13 Mar he was evaluated for a 2 wk hx of flu like sx, and was diagnosed as having pharyngitis. On 07 Apr 08 he was due to receive AVA #2 (reports that AVA #2 was admin), he presented to immunizations but required a walk in visit for evaluation for headache for 2 days and facial tingling. Neuro was consulted and noted that sx likely related to recent AVA, which could unmask previous damage caused by GBS. Per T-con he was reported as doing well on 10 Apr 08, and on 14 Apr he denied any new numbness/tingling, no worsening of previous sx but did report generalized fatigue. On 15 Apr 08 he reported sx have resolved but is now having trouble breathing and SOB with activity. Sx were assessed as not being consistent with GBS and labs were ordered. On 17 Apr pt was told that he had mono with a pos heterophile Ab; his sx included fatigue, sore throat and malaise. Since Apr 08, he has not received any additional vaccinations, was deployed, and has had no recurrent symptoms.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Skin warm
Clinical narrative: Large erythematous, non-painful, warm area on (R) deltoid with mild swelling, measuring approx 12 cm x 6 cm.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Erythema, Skin warm
Clinical narrative: Large erythematous, warm area below injection site measuring about 10 x 8 cm.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling at the injection site, not warm or painful.  Increased over the next 24h
Age: 58.0
Sex: M
Vaccine: FLUX
Symptoms: Mobility decreased, Muscular weakness, Pain, Sleep disorder
Clinical narrative: Arm extremely weak, aching, unable to lift anything heavier than a coffee cup for months after the shot. Could not sleep on that side...treatment listed below
Age: 1.09
Sex: M
Vaccine: HEPA, MMR, VARCEL
Symptoms: Pyrexia, Screaming
Clinical narrative: Developed high fever, 103.F, and screaming uncontrollably.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Ear pain, Headache, Hypoaesthesia facial
Clinical narrative: c/o HA, left ear pain, left facial numbness x2 days
Age: 31.0
Sex: F
Vaccine: HIBV, PPV, TD
Symptoms: Activities of daily living impaired, Injection site erythema, Injection site pain, Injection site swelling, Myalgia
Clinical narrative: Started feeling achy and arm was sore initially but really began hurting redness swelling at site. On 5/10/11 unable to attend work due to severe muscle aches and fever 100.5. Today on 5/11/2011 swelling redness at site is 3 inches by 3 inches feeling better but still very achy fever this am 100.1.
Age: 31.0
Sex: F
Vaccine: HIBV, PPV, TD
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: Started feeling achy and arm was sore initially but really began hurting redness swelling at site. On 5/10/11 unable to attend work due to severe muscle aches and fever 100.5. Today on 5/11/2011 swelling redness at site is 3 inches by 3 inches feeling better but still very achy fever this am 100.1.
Age: 12.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, VARCEL
Symptoms: Cold sweat, Dizziness, Dysphagia, Headache, Injection site erythema
Clinical narrative: Ringing in ears, dizziness, felt throat swelling, hard to swallow, swelling and redness at site, headache, pale, clammy to touch
Age: 12.0
Sex: F
Vaccine: HEPA, HPV4, TDAP, VARCEL
Symptoms: Injection site swelling, Pallor, Pharyngeal oedema, Tinnitus
Clinical narrative: Ringing in ears, dizziness, felt throat swelling, hard to swallow, swelling and redness at site, headache, pale, clammy to touch
Age: 0.15
Sex: F
Vaccine: DTAPHEPBIP, HIBV, RV5
Symptoms: Abdominal pain, Diarrhoea, Irritability, Pyrexia, Stool analysis
Clinical narrative: Severe diarrhea, abdominal pain, fever, fussiness, irritability
Age: 1.0
Sex: F
Vaccine: DTAPIPVHIB
Symptoms: Epistaxis
Clinical narrative: Bloody nose, a lot of blood
Age: 34.0
Sex: F
Vaccine: PPV, TTOX
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth, Myalgia
Clinical narrative: Nausea and fever (99.8) lasted one day.  Muscle aches last for 2.5 days.  Injection site reaction on right arm (where PPSV was administered) with 4-in x 2-in redness, swelling, & pain (both to the touch & to movement of arm). Site reaction was also hot to the touch.
Age: 34.0
Sex: F
Vaccine: PPV, TTOX
Symptoms: Nausea, Pain, Pyrexia
Clinical narrative: Nausea and fever (99.8) lasted one day.  Muscle aches last for 2.5 days.  Injection site reaction on right arm (where PPSV was administered) with 4-in x 2-in redness, swelling, & pain (both to the touch & to movement of arm). Site reaction was also hot to the touch.
Age: 61.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Swelling, redness & pain on injection site (L) deltoid (6 x 7 inches).
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Crying, Erythema, Irritability, Pain, Skin warm
Clinical narrative: Later in the day, pt developed pain around vaccine site, atypically crying and fussy. The following day she developed increased redness, mild swelling and achy pain. (+) hot to the touch.
Age: 4.0
Sex: F
Vaccine: DTAPIPV
Symptoms: Swelling, Vaccination site pain
Clinical narrative: Later in the day, pt developed pain around vaccine site, atypically crying and fussy. The following day she developed increased redness, mild swelling and achy pain. (+) hot to the touch.
Age: 4.0
Sex: F
Vaccine: DTAP, IPV, MMR, PNC13, VARCEL
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Client given vaccines in am, at about 8 pm of same day client started vomiting and developed a low grade fever (99.8). Client cont to have nausea and vomiting, low grade fever into the next day.
Age: 32.0
Sex: F
Vaccine: MNQ
Symptoms: Musculoskeletal stiffness, Nausea, Pyrexia, Vomiting
Clinical narrative: Tues vaccine. Symptoms Tues pm 8:00pm. Stiff neck, nausea, vomit, fever 101. Thurs vomit, fever 101.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Eye swelling, Eyelids pruritus, Skin ulcer, Tenderness
Clinical narrative: Shot admin. 1/11/08. 1/18/08 break out upper Rt eyelid outer corner. Itchy & tender, eye swollen, red open sore. Contained to the eye. 1/30/08 swelling & sore almost healed, still somewhat itchy using OTC NEOSPORIN & hydrocortisone, cold press.
Age: 57.0
Sex: M
Vaccine: HEPAB, TDAP
Symptoms: Heart rate increased, Malaise, Palpitations, Pyrexia, Rash
Clinical narrative: Cl states he got a sudden fever felt very ill & heart rate went up 100-130 & was pounding. About 12 hrs after taking med. Took at 4:30 PM woke at 4 AM with sx.
Age: 35.0
Sex: F
Vaccine: VARCEL
Symptoms: Headache, Pain, Pyrexia, Rash
Clinical narrative: States developed "chicken pox" type rash on 12/26/08. C/O achiness, fever, headache.
Age: 0.53
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC
Symptoms: Injection site papule, Injection site rash
Clinical narrative: Papular non-erythematous rash around injection sites, right & left hip with 3 days of injection at 4 months and 6 months.
Age: 1.0
Sex: F
Vaccine: HIBV, MMR, PNC13, VARCEL
Symptoms: Blood electrolytes normal, Febrile convulsion, Full blood count, Pyrexia, Rhinorrhoea
Clinical narrative: Runny nose, febrile seizure the evening of immunizations. Seen in Emergency Department. Fever control.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, VARCEL
Symptoms: Pruritus, Urticaria
Clinical narrative: Urticaria on face, itching, but he was alert awake, after 30 minutes of the vaccines. He was given BENADRYL 17.5 mg by mouth, he was referred to the ER for observation where he stayed 3 hours then d/c home.
Age: 68.0
Sex: F
Vaccine: PPV
Symptoms: Hyperaesthesia, Musculoskeletal pain, Pain in extremity
Clinical narrative: Severe (L) arm/shoulder pain skin sensitivity within 24hrs of vaccination. Tx: ice, NSAIDS, if persists Rx prednisone.
Age: 0.35
Sex: F
Vaccine: DTAPHEPBIP, HIBV
Symptoms: Injection site erythema, Injection site swelling, Injection site urticaria
Clinical narrative: (L) leg swelling, redness, hives x 2 episodes 2-3-11 vaccine, 4-5-11 vaccine.
Age: 17.0
Sex: M
Vaccine: TYP
Symptoms: Nausea, Pruritus generalised, Urticaria
Clinical narrative: Started taking typhoid (VIVOTIF) #1 Fri May 6. Dose #2 my May 8. On 5/10 evening began to feel nausea & generalizing itching. SOB negative. Noticed at 10:15 had hives buttock & knees - to ER. Took BENADRYL. Stopped typhoid on 5/11. Still with hives - continue with BENADRYL.
Age: 23.0
Sex: F
Vaccine: HEP, HPV4
Symptoms: Computerised tomogram head, Computerised tomogram normal, Contusion, Syncope, Vision blurred
Clinical narrative: Syncope, responsive after < 30 seconds. Stable vital signs. Contusion (R) forehead. To ER with c/o blurred vision. Client reports released from ER after normal findings on CT scan of head.
Age: 1.02
Sex: M
Vaccine: MMR, HEPA, MMR, VARCEL
Symptoms: Otitis media, Upper respiratory tract infection
Clinical narrative: (R) OM/URI.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Patient demonstrate a very large site rxn > 3" diameter with some elongation down arm. Had erythema, itching and warmth.
Age: 65.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site mass, Injection site pruritus, Injection site warmth
Clinical narrative: Patient demonstrate a very large site rxn > 3" diameter with some elongation down arm. Had erythema, itching and warmth.
Age: 1.1
Sex: M
Vaccine: MMRV
Symptoms: Decreased appetite, Insomnia, Pyrexia
Clinical narrative: Fever, not sleeping, not eating.
Age: 33.0
Sex: F
Vaccine: MMR
Symptoms: Disorientation, Dizziness, Nausea
Clinical narrative: Gave MMR - within minutes - pt was very dizzy, nauseated - some disorientation. No difficulty breathing - BP stable. No itching.
Age: 0.48
Sex: F
Vaccine: DTAPIPVHIB, HEP, PNC13, RV5
Symptoms: Crying, Irritability, Vomiting
Clinical narrative: Excessive crying, irritability on day of vaccine. Vomiting x 3 on 5/10/2011.